Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2014 - Issue 4
Submit an article Journal homepage
361
Views
5
CrossRef citations to date
0
Altmetric
COMMENTARY

Disease ‘Activity’, ‘Severity’ and ‘Impact’: Interrelationships in COPD; Is a Measure of Disease ‘Activity’ the Holy Grail for COPD, or a Variable Impossible to Quantify?

Richard I. CarterCentre for Translational Inflammation Research, University of Birmingham Research Laboratories, Birmingham, United Kingdom
&
Robert A. StockleyThe ADAPT Project, Queen Elizabeth Hospital Birmingham, United KingdomCorrespondence[email protected]
Pages 363-367 | Published online: 25 Feb 2014

References

  • Agusti A, Macnee W. The COPD control panel: towards personalised medicine in COPD. Thorax 2013;68:7: 687–690.
  • Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed—urgently. Am J Respir Crit Care Med 2010; 182(7):863–864.
  • Calverley PM, Burge PS, Spencer S, Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58(8):659–664.
  • Quanjer PH, Schouten JP, Miller MR, Avoiding bias in the annualized rate of change of FEV1. Am J Respir Crit Care Med 2007; 175(3):291–292; author reply 292.
  • Stavem K, Aaser E, Sandvik L, Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005; 25(4):618–625.
  • Duvoix A, Dickens J, Haq I, Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013;68:7: 670–676.
  • Vestbo J, Edwards LD, Scanlon PD, Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365(13):1184–1192.
  • Lomas DA, Silverman EK, Edwards LD, Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008; 63(12):1058–1063.
  • Stockley RA. Biomarkers in COPD: time for a deep breath. Thorax 2007; 62(8):657–660.
  • Lindberg CA, Engstrom G, de Verdier MG, Total desmosines in plasma and urine correlate with lung function. Eur Respir J 2012; 39(4):839–845.
  • Carter RI, Mumford RA, Treonze KM, The fibrinogen cleavage product A{alpha}-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax 2011; 66(8):686–691.
  • Carter RI, Ungurs MJ, Mumford RA, Aalpha-Val360: A marker of neutrophil elastase and COPD disease activity. Eur Respir J 2013; 41(1):31–38.
  • Parr DG, White AJ, Bayley DL, Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res 2006; 7:136.
  • Gompertz S, O'Brien C, Bayley DL, Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Euro Respir J: Off J Euro Soc Clin Respir Physiol 2001; 17(6):1112–1119.
  • Dickens JA, Miller BE, Edwards LD, COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011; 12:146.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.